Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer
Despite the significant advances in the treatment of high-risk prostate cancer, patients with very high-risk features such as being locally advanced (clinical stage T3–4 or minimal nodal involvement), having a high Gleason pattern, or with oligometastasis may still have a poor prognosis despite aggr...
Main Authors: | Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Atsushi Mizokami |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/17/4470 |
Similar Items
-
Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer
by: Akbar N. Ashrafi, et al.
Published: (2020-09-01) -
Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis
by: Kim K, et al.
Published: (2021-02-01) -
Two cases of oligometastatic castration‐resistant prostate cancer detected by diffusion‐weighted whole‐body imaging with background body signal suppression
by: Yuki Shimizu, et al.
Published: (2020-03-01) -
Oligometastatic Adenocarcinoma of the Esophagus: Current Understanding, Diagnosis, and Therapeutic Strategies
by: Michael P. Rogers, et al.
Published: (2021-08-01) -
Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
by: Claessens, M., et al.
Published: (2022)